FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044246626> ?p ?o ?g. }

• W3044246626 endingPage "2818" @default.
• W3044246626 startingPage "2807" @default.
• W3044246626 abstract "Acute myeloid leukemia (AML) is a heterogeneous malignancy with the most common genomic alterations in NPM1, DNMT3A, and FLT3. Midostaurin was the first FLT3 inhibitor FDA approved for AML and is standard of care for FLT3 mutant patients undergoing induction chemotherapy [1, 2]. As there is a spectrum of response, we hypothesized that biological factors beyond FLT3 could play a role in drug sensitivity and that select FLT3-ITD negative samples may also demonstrate sensitivity. Thus, we aimed to identify features that would predict response to midostaurin in FLT3 mutant and wild-type samples. We performed an ex vivo drug sensitivity screen on primary and relapsed AML samples with corresponding targeted sequencing and RNA sequencing. We observed a correlation between FLT3-ITD mutations and midostaurin sensitivity as expected and observed KRAS and TP53 mutations correlating with midostaurin resistance in FLT3-ITD negative samples. Further, we identified genes differentially expressed in sensitive vs. resistant samples independent of FLT3-ITD status. Within FLT3-ITD mutant samples, over-expression of RGL4, oncogene and regulator of the Ras-Raf-MEK-ERK cascade, distinguished resistant from sensitive samples. Overall, this study highlights the complexity underlying midostaurin response. And, our results suggest that therapies that target both FLT3 and MAPK/ERK signaling may help circumvent some cases of resistance." @default.
• W3044246626 created "2020-07-29" @default.
• W3044246626 creator A5013231204 @default.
• W3044246626 creator A5014545118 @default.
• W3044246626 creator A5033023115 @default.
• W3044246626 creator A5050348105 @default.
• W3044246626 creator A5058340446 @default.
• W3044246626 creator A5081773810 @default.
• W3044246626 date "2020-07-21" @default.
• W3044246626 modified "2023-09-23" @default.
• W3044246626 title "Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients" @default.
• W3044246626 cites W1895110908 @default.
• W3044246626 cites W1974674483 @default.
• W3044246626 cites W1988528233 @default.
• W3044246626 cites W2018699543 @default.
• W3044246626 cites W2038824910 @default.
• W3044246626 cites W2083221109 @default.
• W3044246626 cites W2098480759 @default.
• W3044246626 cites W2108068107 @default.
• W3044246626 cites W2110502951 @default.
• W3044246626 cites W2114942826 @default.
• W3044246626 cites W2115707319 @default.
• W3044246626 cites W2130116522 @default.
• W3044246626 cites W2130410032 @default.
• W3044246626 cites W2138601221 @default.
• W3044246626 cites W2143835472 @default.
• W3044246626 cites W2155943701 @default.
• W3044246626 cites W2321348439 @default.
• W3044246626 cites W2499799649 @default.
• W3044246626 cites W2526397866 @default.
• W3044246626 cites W2551516978 @default.
• W3044246626 cites W2559537906 @default.
• W3044246626 cites W2568241647 @default.
• W3044246626 cites W2581732250 @default.
• W3044246626 cites W2586764322 @default.
• W3044246626 cites W2592332357 @default.
• W3044246626 cites W2615474766 @default.
• W3044246626 cites W2620184199 @default.
• W3044246626 cites W2620653306 @default.
• W3044246626 cites W2624245118 @default.
• W3044246626 cites W2654449699 @default.
• W3044246626 cites W2715749014 @default.
• W3044246626 cites W2726135378 @default.
• W3044246626 cites W2742198474 @default.
• W3044246626 cites W2747030014 @default.
• W3044246626 cites W2754250453 @default.
• W3044246626 cites W2775490302 @default.
• W3044246626 cites W2783987461 @default.
• W3044246626 cites W2793225437 @default.
• W3044246626 cites W2807088556 @default.
• W3044246626 cites W2809488700 @default.
• W3044246626 cites W2896480326 @default.
• W3044246626 cites W2904378474 @default.
• W3044246626 cites W2972342322 @default.
• W3044246626 cites W2977354624 @default.
• W3044246626 cites W2979782664 @default.
• W3044246626 cites W3000515035 @default.
• W3044246626 cites W918891332 @default.
• W3044246626 doi "https://doi.org/10.18632/oncotarget.27656" @default.
• W3044246626 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7381100" @default.
• W3044246626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32754299" @default.
• W3044246626 hasPublicationYear "2020" @default.
• W3044246626 type Work @default.
• W3044246626 sameAs 3044246626 @default.
• W3044246626 citedByCount "4" @default.
• W3044246626 countsByYear W30442466262021 @default.
• W3044246626 countsByYear W30442466262022 @default.
• W3044246626 crossrefType "journal-article" @default.
• W3044246626 hasAuthorship W3044246626A5013231204 @default.
• W3044246626 hasAuthorship W3044246626A5014545118 @default.
• W3044246626 hasAuthorship W3044246626A5033023115 @default.
• W3044246626 hasAuthorship W3044246626A5050348105 @default.
• W3044246626 hasAuthorship W3044246626A5058340446 @default.
• W3044246626 hasAuthorship W3044246626A5081773810 @default.
• W3044246626 hasBestOaLocation W30442466261 @default.
• W3044246626 hasConcept C203014093 @default.
• W3044246626 hasConcept C2776481607 @default.
• W3044246626 hasConcept C2778461978 @default.
• W3044246626 hasConcept C2778729363 @default.
• W3044246626 hasConcept C2779282312 @default.
• W3044246626 hasConcept C2780035454 @default.
• W3044246626 hasConcept C502942594 @default.
• W3044246626 hasConcept C71924100 @default.
• W3044246626 hasConcept C86803240 @default.
• W3044246626 hasConcept C98274493 @default.
• W3044246626 hasConceptScore W3044246626C203014093 @default.
• W3044246626 hasConceptScore W3044246626C2776481607 @default.
• W3044246626 hasConceptScore W3044246626C2778461978 @default.
• W3044246626 hasConceptScore W3044246626C2778729363 @default.
• W3044246626 hasConceptScore W3044246626C2779282312 @default.
• W3044246626 hasConceptScore W3044246626C2780035454 @default.
• W3044246626 hasConceptScore W3044246626C502942594 @default.
• W3044246626 hasConceptScore W3044246626C71924100 @default.
• W3044246626 hasConceptScore W3044246626C86803240 @default.
• W3044246626 hasConceptScore W3044246626C98274493 @default.
• W3044246626 hasIssue "29" @default.
• W3044246626 hasLocation W30442466261 @default.
• W3044246626 hasLocation W30442466262 @default.

• next